Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William S. Hancock is active.

Publication


Featured researches published by William S. Hancock.


Analytical Chemistry | 1997

Analysis of Oligonucleotides by HPLC-Electrospray Ionization Mass Spectrometry.

Alex Apffel; John A Chakel; Steven M. Fischer; and Kay Lichtenwalter; William S. Hancock

A new interface procedure has been developed that allows, for the first time, the high-efficiency analysis of synthetic oligonucleotides up to 75 bases by reversed-phase HPLC and on-line electrospray ionization mass spectrometry. For oligonucleotides up to 30 bases in length, single-base resolution can be obtained with low levels of cation adduct formation in the negative ion electrospray mass spectra. A key part of the method uses 1,1,1,3,3,3-hexafluoro-2-propanol as an additive to the HPLC mobile phase, adjusted to pH 7.0 with triethylamine. This novel additive results in both good HPLC separation and efficient electrospray ionization. The broad potential of this new method is demonstrated for synthetic homopolymers of thymidine (PolyT), fragments based on the pBR322 plasmid sequence, and phosphorothioate ester antisense oligonucleotides. This approach will be of particular utility for the characterization of DNA probes and PCR primers and quality control of antisense compounds such as phosphorothioates and their metabolites, as well as of materials used in clinical trials.


Molecular & Cellular Proteomics | 2011

The human proteome project: current state and future direction.

Pierre Legrain; Ruedi Aebersold; Alexander I. Archakov; Amos Marc Bairoch; Kumar Bala; Laura Beretta; John J. M. Bergeron; Christoph H. Borchers; Garry L. Corthals; Catherine E. Costello; Eric W. Deutsch; Bruno Domon; William S. Hancock; Fuchu He; Denis F. Hochstrasser; György Marko-Varga; Ghasem Hosseini Salekdeh; Salvatore Sechi; Michael Snyder; Sudhir Srivastava; Mathias Uhlén; Cathy H. Wu; Tadashi Yamamoto; Young-Ki Paik; Gilbert S. Omenn

After the successful completion of the Human Genome Project, the Human Proteome Organization has recently officially launched a global Human Proteome Project (HPP), which is designed to map the entire human protein set. Given the lack of protein-level evidence for about 30% of the estimated 20,300 protein-coding genes, a systematic global effort will be necessary to achieve this goal with respect to protein abundance, distribution, subcellular localization, interaction with other biomolecules, and functions at specific time points. As a general experimental strategy, HPP research groups will use the three working pillars for HPP: mass spectrometry, antibody capture, and bioinformatics tools and knowledge bases. The HPP participants will take advantage of the output and cross-analyses from the ongoing Human Proteome Organization initiatives and a chromosome-centric protein mapping strategy, termed C-HPP, with which many national teams are currently engaged. In addition, numerous biologically driven and disease-oriented projects will be stimulated and facilitated by the HPP. Timely planning with proper governance of HPP will deliver a protein parts list, reagents, and tools for protein studies and analyses, and a stronger basis for personalized medicine. The Human Proteome Organization urges each national research funding agency and the scientific community at large to identify their preferred pathways to participate in aspects of this highly promising project in a HPP consortium of funders and investigators.


Nature Biotechnology | 2012

The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome

Young-Ki Paik; Seul Ki Jeong; Gilbert S. Omenn; Mathias Uhlén; Samir M. Hanash; Sang Yun Cho; Hyoung Joo Lee; Keun Na; Eun Young Choi; Fangfei Yan; Fan Zhang; Yue Zhang; Michael Snyder; Yong Cheng; Rui Chen; György Marko-Varga; Eric W. Deutsch; Hoguen Kim; Ja Young Kwon; Ruedi Aebersold; Amos Marc Bairoch; Allen D. Taylor; Kwang Youl Kim; Eun Young Lee; Denis F. Hochstrasser; Pierre Legrain; William S. Hancock

The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome


Analytical Biochemistry | 1976

A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzene-sulphonic acid

William S. Hancock; J.E. Battersby

Abstract A rapid micro-test using 2,4,6-trinitrobenzenesulphonic acid has been developed to detect incomplete coupling reactions in solid phase peptide synthesis. This new test will detect 3 nmol of free amino groups per milligram of resin.


Biotechnology Progress | 2008

Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs

Xiaoyang Zheng; Haven Baker; William S. Hancock; Farah Fawaz; Michael Mccaman; Erno Pungor

Fetal bovine serum (FBS) is the most widely used growth supplement for cell cultures, primarily because of its high levels of growth stimulatory factors and low levels of growth inhibitory factors. Maintaining successful and consistent cell fermentations can be difficult, as FBS is a complex natural product and may vary from lot to lot even from a single manufacturer. The quality and concentration of both bulk and specific proteins can affect cell growth. Quality control tools for FBS are relatively primitive and expensive given the complexity of the sample and the large amounts of FBS used. We undertook this study to examine whether proteomics could be used as a tool to analyze the variability of different fermentation processes. We hypothesized that inconsistent cell growth in fermentations could be due to the quality of FBS and that different lots of FBS had varying concentrations of proteins such as growth stimulatory factors, growth inhibitory factors, and/or other proteins that may correlate with cellular growth rate. To investigate whether this was the case, we grew three batches of adult retinal pigment epithelial cells (ARPE‐19) using three different lots of fetal bovine serum (FBS‐Ia, FBS‐Ib, and FBS‐II). We found that the growth rate of the culture was significantly and consistently higher in the FBS‐II lot. To determine why the other lots promoted different growth properties, we used proteomic techniques to analyze the protein composition of the three lots. We then performed a time course study to monitor specific changes in individual proteins in the fermentation medium. The amount of several extracellular matrix and structural proteins, which are indicators of cell growth, increased over time. Alternatively, components supplied by the FBS addition, such as nutritional‐related and cell‐spreading‐related proteins, decreased over time.


Journal of Chromatography A | 1978

High-pressure liquid chromatography of peptides and proteins : II. The use of phosphoric acid in the analysis of under-ivatised peptides by reversed-phase high-pressure liquid chromatography

William S. Hancock; C.A. Bishop; R.L. Prestidge; D.R.K. Harding; Milton T. W. Hearn

Abstract The chromatographic properties of a range of peptides varying in size from di- to decapeptide have been investigated by reversed-phase high-pressure liquid chromatography. A new set of conditions, namely, the addition of phosphoric acid to the mobile phase, has been found to have very real advantages in the analysis of underivatised peptides. These conditions allowed marked alterations in retention times, improvement in reproducibility and excellent resolution of peptides differing by as little as a single amino acid. A major advantage of phosphoric acid is that it can be used successfully in the range 195–220 nm which makes it compatible with the use of variable wavelength UV monitors as sensitive detectors in high-pressure liquid chromatography. In addition, the use of phosphoric acid permits the significant lowering of concentrations of organic solvents in the mobile phase, thus reducing the possibility of denaturation or precipitation.


Journal of Chromatography A | 1989

Characterization of human growth hormone by capillary electrophoresis

John Frenz; Shiaw-Lin Wu; William S. Hancock

Production of proteins by recombinant DNA technology for use as pharmaceuticals requires the use of the most powerful tools of analytical protein chemistry in order to confirm purity and identity of the product and reliability of the process. Capillary electrophoresis is an emerging technology that shows high sensitivity and selectivity and may have promise in this application. The technique combines the instrumental control and quantification features of high-performance liquid chromatography with the separating power of electrophoresis, and thereby has attracted broad interest. In this report, human growth hormone expressed in bacteria has been analyzed by both free zone electrophoresis and isoelectric focusing in a coated capillary to demonstrate the separation of the native molecule from its deamidated variant. A capillary zone electrophoretic tryptic map has also been developed and characterized. This map complements the widely employed reversed-phase high-performance liquid chromatography tryptic mapping systems that are important in protein characterization. Certain drawbacks to capillary zone electrophoresis compared to other analytical methods are noted, including relatively poor reproducibility and low sample tolerance. For applications as demonstrated here, however, the speed, separating power and sensitivity of the technique compensate for these shortcomings.


Journal of Proteome Research | 2012

Standard guidelines for the chromosome-centric human proteome project.

Young-Ki Paik; Gilbert S. Omenn; Mathias Uhlén; Samir M. Hanash; György Marko-Varga; Ruedi Aebersold; Amos Marc Bairoch; Tadashi Yamamoto; Pierre Legrain; Hyoung-Joo Lee; Keun Na; Seul-Ki Jeong; Fuchu He; Pierre-Alain Binz; Toshihide Nishimura; Paul Keown; Mark S. Baker; Jong Shin Yoo; Jérôme Garin; Alexander I. Archakov; John J. M. Bergeron; Ghasem Hosseini Salekdeh; William S. Hancock

The objective of the international Chromosome-Centric Human Proteome Project (C-HPP) is to map and annotate all proteins encoded by the genes on each human chromosome. The C-HPP consortium was established to organize a collaborative network among the research teams responsible for protein mapping of individual chromosomes and to identify compelling biological and genetic mechanisms influencing colocated genes and their protein products. The C-HPP aims to foster the development of proteome analysis and integration of the findings from related molecular -omics technology platforms through collaborations among universities, industries, and private research groups. The C-HPP consortium leadership has elicited broad input for standard guidelines to manage these international efforts more efficiently by mobilizing existing resources and collaborative networks. The C-HPP guidelines set out the collaborative consensus of the C-HPP teams, introduce topics associated with experimental approaches, data production, quality control, treatment, and transparency of data, governance of the consortium, and collaborative benefits. A companion approach for the Biology and Disease-Driven HPP (B/D-HPP) component of the Human Proteome Project is currently being organized, building upon the Human Proteome Organizations organ-based and biofluid-based initiatives (www.hupo.org/research). The common application of these guidelines in the participating laboratories is expected to facilitate the goal of a comprehensive analysis of the human proteome.


Analytical Chemistry | 2009

Mass Spectrometric Determination of Disulfide Linkages in Recombinant Therapeutic Proteins Using Online LC−MS with Electron-Transfer Dissociation

Shiaw-Lin Wu; Haitao Jiang; Qiaozhen Lu; Shujia Dai; William S. Hancock; Barry L. Karger

In the biotechnology industry, the generation of incorrectly folded recombinant proteins, either from an E.coli expression system or from an overexpressed CHO cell line (disulfide scrambling), is often a great concern as such incorrectly folded forms may not be completely removed in the final product. Thus, significant efforts have been devoted to map disulfide bonds to ensure drug quality. Similar to ECD, disulfide bond cleavages are preferred over peptide backbone fragmentation in ETD. Thus, an online LC-MS strategy combining collision-induced dissociation (CID-MS(2)), electron-transfer dissociation (ETD-MS(2)), and CID of an isolated product ion derived from ETD (MS(3)) has been used to characterize disulfide-linked peptides. Disulfide-linked peptide ions were identified by CID and ETD fragmentation, and the disulfide-dissociated (or partially dissociated) peptide ions were characterized in the subsequent MS(3) step. The online LC-MS approach is successfully demonstrated in the characterization of disulfide linkages of recombinant human growth hormone (Nutropin), a therapeutic monoclonal antibody, and tissue plasminogen activator (Activase). The characterization of disulfide-dissociated or partially dissociated peptide ions in the MS(3) step is important to assign the disulfide linkages, particularly, for intertwined disulfide bridges and the unexpected disulfide scrambling of tissue plasminogen activator. The disulfide-dissociated peptide ions are shown to be obtained either directly from the ETD fragmentation of the precursors (disulfide-linked peptide ions) or indirectly from the charge-reduced species in the ETD fragmentation of the precursors. The simultaneous observation of disulfide-linked and disulfide-dissociated peptide ions with high abundance not only provided facile interpretation with high confidence but also simplified the conventional approach for determination of disulfide linkages, which often requires two separate experiments (with and without chemical reduction). The online LC-MS with ETD methodology represents a powerful approach to aid in the characterization of the correct folding of therapeutic proteins.


Journal of Chromatography A | 1997

New procedure for the use of high-performance liquid chromatography–electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides

Alex Apffel; John A Chakel; Steven M. Fischer; Kay Lichtenwalter; William S. Hancock

Abstract A method is described which allows the combination of high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides without compromising the performance of either technique. The essential feature of the method uses 1,1,1,3,3,3-hexafluoro-2-isopropanol as an additive to the HPLC mobile phase. This novel additive results in both good HPLC separation and efficient negative ion mode electrospray ionization. The method is demonstrated for oligonucleotides samples such as synthetic homopolymers of thymidine (PolyT), of fragments based on the pBR322 plasmid sequence and analysis of phosphorothioate ester antisense oligonucleotides. The differentiation of phosphorylation states of natural nucleotides as well as nucleotide analogues, such as ziduvodine (AZT), is also demonstrated.

Collaboration


Dive into the William S. Hancock's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shiaw-Lin Wu

Northeastern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge